CD73-BLOCKADE

Patent europeic · EP3259288 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3259288
Numer da la dumonda
EP16709299
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
19-02-2016
Publitgà
27-12-2017
Concedì
22-07-2026
La protecziun finescha il pli tard
18-02-2036
Proxima taxa annuala scadenta
28-02-2027
Classas IPC
C07K 16/28 (2006.01)
C07K 16/40 (2006.01)
C07K 16/30 (2006.01)
Prioritad
US 201562118549 P 20.02.2015
US 201562133597 P 16.03.2015
US 201562188881 P 06.07.2015
WO PCT/EP2015/073370 09.10.2015
US 201662281841 P 22.01.2016
Dumonda PCT
PCT/EP2016/053539 19.02.2016
Publicaziun PCT
WO2016/131950 25.08.2016
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 22-07-2026

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 22.07.2026

Partidas

Possessur

Innate Pharma

117, Avenue de Luminy, 13009 Marseille, FR

Inventur

CHANTEUX, Stéphanie

13009 Marseille, FR

PATUREL, Carine

69280 Marcy l'Etoile, FR

PERROT, Ivan

13830 Roquefort la Bedoule, FR

GAUTHIER, Laurent

13008 Marseille, FR

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.